Adaptimmune治療公共 ADAP 深 滬
已收盤 09-26 16:00:00 美东时间
0.147
+0.020
+15.75%
華盛通- 最 高0.162
- 今 開0.133
- 成交量 8674.03万股
- 最 低 0.133
- 昨 收 0.127
- 總市值 3895.50万
- 52周最高 0.9599
- 市盈率 靜 --
- 換手率 32.73%
- 52周最低 0.0403
- 委 比 -97.88%
- 總股本 2.65亿
- 歷史最高 21.57
- 量 比 0.50
- 振 幅 22.83%
- 歷史最低 0.0403
- 每 手 1
- 風險率 0.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Adaptimmune Granted Exception Period by Nasdaq Panel
The latest announcement is out from Adaptimmune Therapeutics ( ($ADAP) ). On Se...
09-27 05:06
Why FedEx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Shares of FedEx Corporation (NYSE:FDX) rose sharply in pre-market trading after...
09-19 17:25
Adaptimmune Appoints New CFO Christopher Hill
Adaptimmune Therapeutics ( ($ADAP) ) just unveiled an announcement. On Septembe...
09-09 04:37
Applied Digital Finalizes Additional 150MW Lease with CoreWeave in North Dakota
Applied Digital has finalized a new 150MW lease agreement with CoreWeave, bringing total capacity at its Polaris Forge 1 Campus to 400MW. This brings Applied Digital's anticipated revenue from these deals to $11B. The additional capacity will be housed in the third building of the campus, set to be operational in 2027. The campus is designed to scale up to 1GW, leveraging renewable energy and North Dakota's climate to reduce costs and emissions. ...
08-29 12:00
Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win
Argenx advances Vyvgart with strong trial data in seronegative gMG, driving growth projections and reinforcing its leadership in IgG-driven diseases.
08-27 01:35
Adaptimmune Therapeutics Stock (ADAP) Rockets 50% on CCO Severance Agreement
Adaptimmune Therapeutics stock rallied after the company reached a severance ag...
08-18 20:26
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Shares of Dayforce Inc (NYSE:DAY) rose sharply in pre-market trading. Bloomberg...
08-18 18:51
Adaptimmune Announces CCO Departure and Severance Agreement
Adaptimmune Therapeutics ( ($ADAP) ) has shared an update. On August 15, 2025, ...
08-16 05:06
Adaptimmune Therapeutics Q2 EPS $(0.02) Beats $(0.08) Estimate, Sales $13.677M Beat $9.914M Estimate
Adaptimmune Therapeutics (NASDAQ:ADAP) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.08) by 76.19 percent. This is a 150 percent decrease over earnings of $0.04 per share
08-13 19:37
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Y-mAbs Therapeutics (NASDAQ:YMAB) stock rose 103.2% to $8.52 during Tu...
08-06 01:06
